Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer

Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Ayako Shiono, Yu Miura, Kosuke Hashimoto, Fuyumi Nishihara, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu

Cancer Chemotherapy and Pharmacology · 2019 · 51 citations · 10 references

Concepts

References

10